Biotechnology

Turmoil in the financial markets is having a disproportionate impact on biotech – and coupled with extra caution from regulators, is threatening innovation.

UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?

The European Commission has selected six areas of pioneering research for its long-awaited lead markets initiative.

Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.

Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.